Inventor · disambiguated record
Tanja Herrmann
Also filed as: HERRMANN TANJA
7 granted patents·9 pending applications·81 citations·filing 2010–2024
83Inventor score
Top patents by PatentIndex Score
16 records- 0191US8388968B2Compositions and methods for increasing muscle growthBERGER CATRIN·Filed 2010·Granted Mar 5, 2013·66 cites·34 claims
- 0284US11292838B2Method for generating antibodies against T cell receptorMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Granted Apr 5, 2022·6 cites·17 claims
- 0384US2024425602A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0479US8551482B2Compositions and methods for increasing muscle growthBERGER CATRIN·Filed 2012·Granted Oct 8, 2013·6 cites·18 claims
- 0577US12018072B2Antibodies specific for human complement C5A receptor (C5AR)MORPHOSYS AG·Filed 2023·Granted Jun 25, 2024·0 cites·30 claims
- 0675US9624293B2Collection and methods for its useMORPHOSYS AG·Filed 2014·Granted Apr 18, 2017·1 cites·14 claims
- 0774US8685896B2Collection and methods for its useENZELBERGER MARKUS·Filed 2010·Granted Apr 1, 2014·2 cites·19 claims
- 0874US2024400657A1Antibodies targeting c5arMORPHOSYS AG·Filed 2024·Application pending·0 cites
- 0961US2018194846A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1058US10647757B2Collection and methods for its useMORPHOSYS AG·Filed 2017·Granted May 12, 2020·0 cites·8 claims
- 1157US2022135658A1Antibodies targeting c5arMORPHOSYS AG·Filed 2020·Application pending·0 cites
- 1257US2013344091A1Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2013·Application pending·0 cites
- 1354US2018134791A9Compositions and methods for increasing muscle growthNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1451US2024228562A1Novel lipocalin muteins specific for connective tissue growth factor (ctgf)PIERIS PHARMACEUTICALS GMBH·Filed 2022·Application pending·0 cites
- 1543US2016060347A1Antibodies targeting specifically human cxcr2MORPHOSYS AG·Filed 2014·Application pending·0 cites
- 1637US2018256716A1T-cell receptor specific antibodiesMEDIGENE IMMUNOTHERAPIES GMBH·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →